Researcher Database

（Last updated : 2025-02-15 08:40:38）　

Visruth.jpg not found

MORIWAKI KENSUKE

Department / Course College of Life Sciences Department of Biomedical Sciences

Title / Position Associate Professor

Other Affiliations
1.	Graduate School of Life Sciences

Present specialized field
Medical pharmacy, Medical sociology, Hygiene and public health

Books
1.	2022	Osteoporotic Fracture and Systemic Skeletal Disorders

Papers
1.	2024/01	Cost-effectiveness Analysis of Nivolumab Plus Ipilimumab Combination Therapy as First-line Treatment for Advanced Renal Cell Carcinoma in Japan │ Value in Health Regional Issues │ 40,pp.118-126
2.	2023/09	Cost-effectiveness analysis of nivolumab plus chemotherapy vs chemotherapy for patients with unresectable advanced or metastatic HER2-negative gastric or gastroesophageal junction or esophageal adenocarcinoma in Japan │ Journal of Gastroenterology │ doi: 10.1007/s00535-023-02041-3
3.	2023/08	Cost-effective analysis of transcatheter aortic valve replacement in patients with severe symptomatic aortic stenosis: A prospective multicenter study │ J Cardiol │ S0914-5087(23)00184-3
4.	2022/09	Cost-effectiveness analysis of universal screening for biliary atresia in Japan │ J Pediatr │ in press
5.	2022/07	Parathyroidectomy versus cinacalcet among patients undergoing hemodialysis │ J Clin Endocrinol Metab │ 107 (7),pp.2016-2025
Display All（34）

Academic conference presentation
1.	2024/05	Cost-Effectiveness Analysis of Blinatumomab for Advanced Acute Lymphoblastic Leukemia in Japan
2.	2024/05	Cost-Effectiveness Analysis of Pembrolizumab + Chemotherapy for Persistent, Recurrent, or Metastatic Cervical Cancer in Japan
3.	2024/05	Cost-Effectiveness Analysis of Pembrolizumab for Advanced Colorectal Cancer with MSI-High or dMMR in Japan
4.	2024/05	Cost-Effectiveness Analysis of Tremelimumab As First-Line Therapy for Metastatic Non-Small Cell Lung Cancer in Japan
5.	2024/05	Economic Evaluation of Duvelisib Versus Ofatumumab in Relapsed/Refractory CLL/SLL in Japan
Display All（51）

Works
1.	2017/03/14	Cost-effective thresholds of ΔNTCP for the use of proton beam therapy

Winning science prize
1.	2007	International Society for Pharmacoeconomics and Outcomes Research ISPOR Best Contributed Poster Presentation Awards

Grants-in-Aid for Scientific Research -KAKENHI-
1.	2020/04 ～ 2024/03	Development of the new healthcare decision support system integrating multiple value-based criteria including cost-effectiveness │ Grant-in-Aid for Scientific Research(C)
2.	2014/04 ～ 2018/03	Empirical study for accumulation of health-related QOL values for health economic evaluation │ Grant-in-Aid for Scientific Research(B)
3.	2014/04 ～ 2017/03	Health economic evaluation of strategies for the prevention and treatment of osteoporosis │ Grant-in-Aid for Young Scientists (B)
4.	2011/04 ～ 2013/03	Health economic evaluation of treatment strategies with biologic agents for rheumatoid arthritis │ Grant-in-Aid for Young Scientists (B)

Competitive grants, etc. (exc. KAKENHI)
1.	2018 ～ 2019	医療経済評価の政策応用に向けた評価手法およびデータの確立と評価体制の整備に関する研究 │ Research by External Competitive Fund │ 厚生労働科学研究費補助金（政策科学推進研究事業）

E-Mail Address

Department laboratory expense researcher number
10514862